Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02750514
Title An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer (FRACTION-Lung)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

Therapies

Dasatinib + Nivolumab

Nivolumab + Relatlimab

Nivolumab

BMS-986205 + Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | AUT


No variant requirements are available.